Healthy high growth potential

Results

1541

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1541 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
6990
HK$520.50-3.5%19.9%HK$124.4bHK$570.0551.945.1%n/aPharmaceuticals & Biotech
1729
HK$16.547.8%38.5%HK$36.9bHK$28.7547.137.1%0.3%Capital Goods
9218
JP¥749.00-0.4%-11.2%JP¥7.9bn/a33.128.9%1.3%Healthcare
002384
CN¥205.195.1%293.7%CN¥374.0bCN¥188.00183.373.1%0%Tech
688270
CN¥66.65-3.5%38.3%CN¥19.9bCN¥185.71132.885.5%0%Semiconductors
AV1
AU$0.07-2.8%-53.3%AU$64.9mAU$0.166.8107.8%n/aSoftware
2368
NT$1,015.003.4%118.0%NT$513.0bNT$1,554.4445.244.0%1.0%Tech
A458870
₩23,950.004.1%112.6%₩911.5b₩62,666.6730.040.0%n/aHealthcare
3277
HK$73.30-1.2%n/aHK$32.6bHK$115.3595.334.2%0.4%Tech
SAATVIKGL
₹427.400.9%n/a₹54.3b₹542.5022.164.0%n/aSemiconductors
3036
NT$210.00-0.7%67.3%NT$266.8bNT$314.8610.928.9%3.7%Tech
7769
NT$6,590.004.3%314.5%NT$1.2tNT$9,210.1868.047.9%1.0%Semiconductors
2171
HK$15.01-2.1%-33.9%HK$8.9bHK$21.1961.080.6%n/aPharmaceuticals & Biotech
2480
HK$13.10-3.7%-44.3%HK$2.6bHK$31.003.477.1%n/aPharmaceuticals & Biotech
RXL
AU$0.482.1%54.8%AU$667.1mAU$0.882.382.7%n/aMaterials
NORTHERN
RM 0.690.7%-2.8%RM 271.0mRM 1.0017.739.5%n/aCapital Goods
3881
HK$19.82-5.3%n/aHK$8.7bn/a5.8119.5%n/aCapital Goods
688192
CN¥60.918.8%-28.5%CN¥28.3bCN¥83.0031.7104.5%n/aPharmaceuticals & Biotech
1357
HK$4.50-5.4%-57.9%HK$20.4bHK$8.7824.031.3%2.2%Media
ADMR
Rp1,680.003.7%66.3%Rp68.7tRp2,344.8613.126.8%2.8%Materials
7685
JP¥3,165.003.4%89.8%JP¥195.7bJP¥4,866.6726.627.0%0.7%Retail
MONOLITH
₹950.252.4%137.6%₹20.7b₹1,060.0072.035.6%n/aMaterials
002975
CN¥99.992.1%159.7%CN¥20.8bCN¥130.0089.444.2%0%Tech
6787
JP¥18,250.00-2.9%128.7%JP¥468.4bJP¥28,400.0023.830.1%0.9%Tech
Page 1 of 43
Healthy high growth potential - Investing Ideas - Simply Wall St